In yesterday’s Wall Street session, BioVie Inc (NASDAQ:BIVI) shares traded at $2.84, up 10.94% from the previous session.
BIVI stock price is now 26.35% away from the 50-day moving average and -45.53% away from the 200-day moving average. The market capitalization of the company currently stands at $47.18M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $7, Cantor Fitzgerald recently initiated with Overweight rating for BioVie Inc (NASDAQ: BIVI). On January 15, 2021, B. Riley Securities recently initiated its ‘Buy’ rating on the stock quoting a target price of $47
In other news, GORLIN STEVE, Director sold 75,680 shares of the company’s stock on Dec 01 ’23. The stock was sold for $127,899 at an average price of $1.69. Upon completion of the transaction, the Director now directly owns 46,358 shares in the company, valued at $0.13 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 30 ’23, President & CEO DO CUONG V bought 10,000 shares of the business’s stock. A total of $17,800 was incurred on buying the stock at an average price of $1.78. This leaves the insider owning 68,759 shares of the company worth $0.2 million. A total of 31.32% of the company’s stock is owned by insiders.
During the past 12 months, BioVie Inc has had a low of $1.04 and a high of $58.20. As of last week, the company has a debt-to-equity ratio of 0.39, a current ratio of 2.57, and a quick ratio of 2.57. The fifty day moving average price for BIVI is $2.2478 and a two-hundred day moving average price translates $5.2137 for the stock.
The latest earnings results from BioVie Inc (NASDAQ: BIVI) was released for 2024-06-30. The company reported revenue of $4.79 million for the quarter, compared to $10.98 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -56.36 percent.
